Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Alina D. Nikotina, Lidia Koludarova, Elena Y. Komarova, Elena R. Mikhaylova, Nikolay D. Aksenov, Roman Suezov, Viktor G. Kartzev, Boris A. Margulis, Irina V. Guzhova
Published Jun 5, 2018 · Vol. 9, No. 43 · pp. 27268-27279
Stefanie Thiele, Ariane Zimmer, Andy Göbel, Tilman D. Rachner, Sandra Rother, Susanne Fuessel, Michael Froehner, Manfred P. Wirth, Michael H. Muders, Gustavo B. Baretton, Franz Jakob, Martina Rauner, Lorenz C. Hofbauer
Published Jun 5, 2018 · Vol. 9, No. 43 · pp. 27293-27304
Aafke Creemers, Eva A. Ebbing, Gerrit K.J. Hooijer, Lisanne Stap, Rajni A. Jibodh-Mulder, Susanne S. Gisbertz, Mark I. van Berge Henegouwen, Maurits L. van Montfoort, Maarten C.C.M. Hulshof, Kausilia K. Krishnadath, Martijn G.H. van Oijen, Maarten F. Bijlsma, Sybren L. Meijer, Hanneke W.M. van Laarhoven
Published Jun 1, 2018 · Vol. 9, No. 42 · pp. 26787-26799
